Literature DB >> 9661938

Community-acquired Clostridium difficile infection.

L Kyne1, C Merry, B O'Connell, C Keane, D O'Neill.   

Abstract

Clostridium difficile-associated disease (CDAD) is primarily a nosocomial condition. Community-acquired disease has been reported but the incidence is felt to be low and the rate of disease resulting in hospitalization is reported as negligible. We recently experienced a 6-month outbreak of CDAD (January to June 1995): 139 patients were involved and four deaths were attributable to pseudomembranous colitis. Early in the outbreak period we were aware that many new admissions presented with C. difficile cytotoxin B positive diarrhoea: in some cases this was the sole reason for hospitalization. This observation forms the basis of this report.

Entities:  

Mesh:

Year:  1998        PMID: 9661938     DOI: 10.1016/s0163-4453(98)94207-4

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  15 in total

1.  In vitro activity of linezolid against Clostridium difficile.

Authors:  T Peláez; R Alonso; C Pérez; L Alcalá; O Cuevas; E Bouza
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  Non-steroidal anti-inflammatory drugs and the risk of Clostridium difficile-associated disease.

Authors:  Daniel Suissa; Joseph A C Delaney; Sandra Dial; Paul Brassard
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

3.  Prevalence of Clostridium difficile in retail pork.

Authors:  Devon Metcalf; Richard J Reid-Smith; Brent P Avery; J Scott Weese
Journal:  Can Vet J       Date:  2010-08       Impact factor: 1.008

4.  Clostridium difficile infection in the community: are proton pump inhibitors to blame?

Authors:  Daniel E Freedberg; Julian A Abrams
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

5.  Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients.

Authors:  L M Søes; I Brock; S Persson; J Simonsen; K E Pribil Olsen; M Kemp
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-10       Impact factor: 3.267

6.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

7.  Michigan Clostridium difficile hospital discharges: frequency, mortality, and charges, 2002-2008.

Authors:  Kerrie E VerLee; Jennie L Finks; Melinda J Wilkins; Eden V Wells
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

Review 8.  The changing epidemiology of Clostridium difficile infections.

Authors:  J Freeman; M P Bauer; S D Baines; J Corver; W N Fawley; B Goorhuis; E J Kuijper; M H Wilcox
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

9.  Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy.

Authors:  S S Johal; J Hammond; K Solomon; P D James; Y R Mahida
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

10.  Clostridium difficile strains from community-associated infections.

Authors:  Brandi M Limbago; Cherie M Long; Angela D Thompson; George E Killgore; George E Hannett; Nancy L Havill; Stephanie Mickelson; Sarah Lathrop; Timothy F Jones; Mahin M Park; Kathleen H Harriman; L Hannah Gould; L Clifford McDonald; Frederick J Angulo
Journal:  J Clin Microbiol       Date:  2009-07-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.